Lakeshore biopharma announces the official launch of a novel packaging solution for ysja™ rabies vaccine (vero cell)

Revolutionizing vaccination safety with needle-free reconstitution technology beijing , april 23, 2025 /prnewswire/ -- on april 18, 2025, lakeshore biopharma co., ltd. (nasdaq: lsb) ("lakeshore biopharma" or the "company") successfully held the 2025 cso ("contract sales organization") annual meeting and the launch meeting of ysja™ rabies vaccine (vero cell) novel packaging solution (liquid drug transfer device) in changsha, hunan province.
LSB Ratings Summary
LSB Quant Ranking